齐夫托梅尼布:首次获得批准
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
Drugs
|February 7, 2026
概括
齐夫托梅尼布是一种新型的脑膜抑制剂,已批准用于患有NPM1突变的复发性或耐药性急性髓性白血病 (AML). 它针对特定的基因相互作用恢复正常细胞发育,并对抗白血病生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有NPM1突变或KMT2A重组的急性髓性白血病 (AML) 存在重大治疗挑战.
- 精子-KMT2A复合体和突变的NPM1蛋白质通过增加瘤基因的转录来驱动白血病发生.
- 针对肌肉相互作用为特定的AML亚型提供了潜在的治疗策略.
研究的目的:
- 总结一下新型脑膜抑制剂齐夫托梅尼布的发展情况.
- 为了突出导致其首次监管批准的里程碑.
- 概述齐夫托梅尼布在NPM1突变AML中的作用机制.
主要方法:
- 对齐夫托梅尼布的临床前和临床发展数据的审查.
- 对药物的作用机制的分析,针对menin-KMT2A复合体.
- 监管提交和批准过程的总结.
主要成果:
- 齐夫托梅尼布在临床前模型和临床试验中对NPM1-突变的AML证明了有效性.
- 该药物选择性地抑制了menin-KMT2A相互作用,降低了白血病原性基因转录的调节.
- 齐夫托梅尼布于2025年11月13日获得美国FDA批准,用于复发性或耐火性NPM1-突变AML的成年人.
结论:
- 齐夫托梅尼布在治疗复发性或耐火性NPM1-突变的AML方面取得了重大进展.
- 它的向机制为那些选择有限的患者提供了新的治疗选择.
- 批准标志着AML精密药物的开发的一个关键里程碑.
相关概念视频
FDA Approved Drugs: Changes to Approved Drugs
273
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
273
Obedience
35.7K
According to obedience research, we may harm others under the forceful pressures of an authority figure (Milgram, 1974). How about if the inappropriate orders were delivered with less force? The increasing interdependence between nurses and physicians compelled Hofling and his colleagues to explore nurses’ reactions to a potentially harmful medical request made by the perceived authority figure, the doctor (Hofling, Brotzman, Dalrymple, Graves, & Pierce, 1966). In this situation,...
35.7K
Ethics in Research
25.8K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
25.8K


